Search

Author/Creator Thiyagarajah, Piruntha

1. Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial. (April 2022)

Authors:
Naidoo, Jarushka; Vansteenkiste, Johan F.; Faivre-Finn, Corinne; Özgüroğlu, Mustafa; Murakami, Shuji; Hui, Rina; Quantin, Xavier; Broadhurst, Helen; Newton, Michael; Thiyagarajah, Piruntha; Antonia, Scott J.
Journal:
Lung cancer
Issue:
Volume 166(2022)
Page Start:
84
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Issue 1 (January 2021)

Authors:
Goldman, Jonathan W; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Garassino, Marina Chiara; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libo...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 1(2021)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer. Issue 12 (20th April 2022)

Authors:
Spigel, David R.; Faivre-Finn, Corinne; Gray, Jhanelle E.; Vicente, David; Planchard, David; Paz-Ares, Luis; Vansteenkiste, Johan F.; Garassino, Marina C.; Hui, Rina; Quantin, Xavier; Rimner, Andreas; Wu, Yi-Long; Özgüroğlu, Mustafa; Lee, Ki H.; Kato, Terufumi; de Wit, Maike; Kurata, Takayasu; Re...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 12(2022)
Page Start:
1301
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗